In 2009, Pfizer Inc. agreed to pay $2.3 billion to resolve civil and criminal allegations that it had illegally promoted the use of certain prescription drugs for uses that were not approved by the U.S. Food and Drug Administration (FDA). This settlement was one of the largest healthcare fraud settlements in U.S. history at the time.

The allegations against Pfizer related to the promotion of four prescription drugs: Bextra, Geodon, Zyvox, and Lyrica. The U.S. Department of Justice (DOJ) alleged that Pfizer had illegally marketed these drugs for uses that were not approved by the FDA, and that the company had promoted the use of these drugs in higher doses and for longer periods of time than were recommended. The DOJ also alleged that Pfizer had paid kickbacks to healthcare providers to encourage them to prescribe these drugs.

The settlement included $1.3 billion in criminal fines and forfeiture, and $1 billion in civil settlements with the U.S. government and various state governments. Pfizer also entered into a corporate integrity agreement with the Office of Inspector General of the Department of Health and Human Services, which required the company to implement measures to ensure compliance with laws and regulations related to the promotion and marketing of its products.

Who was the CEO of Pfizer at the time.

Jeffrey B. Kindler was the CEO of Pfizer Inc. from 2006 to 2010. Prior to becoming CEO, he held various leadership roles at the company, including as Chief Counsel and Chief Strategy Officer.

Mr. Kindler received a bachelor’s degree in political science from the University of Michigan and a law degree from the University of Virginia School of Law. He began his career as an attorney, working for the law firm Covington & Burling in Washington, D.C., and later for the U.S. Department of Justice. He joined Pfizer in 2002 as Chief Counsel and was appointed Chief Strategy Officer in 2004. In 2006, he was named CEO of the company.

During his tenure as CEO, Mr. Kindler focused on expanding Pfizer’s presence in emerging markets and on developing new products, including drugs to treat cancer, Alzheimer’s disease, and cardiovascular disease. He also led the acquisition of Wyeth, a major pharmaceutical company, in 2009.

Mr. Kindler left Pfizer in 2010 and was succeeded as CEO by Ian C. Read. He has since served on the board of directors of several companies, including McDonald’s and

Michael Yeadon was the previous Vice President of Pfizer, who has been actively speaking out against the Covid 19 narrative, and up until then was a highly regarded scientist.  They have done everything they can to smear his impeccable career, and his ethics when he left Pfizer due to their corruption.

Dr. Michael Yeadon

Learn what Awake Canada is Doing to save our Country!